Package 59762-1005-1

Brand: cabergoline

Generic: cabergoline
NDC Package

Package Facts

Identity

Package NDC 59762-1005-1
Digits Only 5976210051
Product NDC 59762-1005
Description

8 TABLET in 1 BOTTLE (59762-1005-1)

Marketing

Marketing Status
Marketed Since 2014-09-22
Brand cabergoline
Generic cabergoline
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "754ad7cd-edf5-4792-890d-07f0e4324c07", "openfda": {"nui": ["M0007652", "N0000175827"], "unii": ["LL60K9J05T"], "rxcui": ["199703"], "spl_set_id": ["e497366b-a124-4d7f-bd45-a883c392d4bb"], "pharm_class_cs": ["Ergolines [CS]"], "pharm_class_epc": ["Ergot Derivative [EPC]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "8 TABLET in 1 BOTTLE (59762-1005-1)", "package_ndc": "59762-1005-1", "marketing_start_date": "20140922"}], "brand_name": "Cabergoline", "product_id": "59762-1005_754ad7cd-edf5-4792-890d-07f0e4324c07", "dosage_form": "TABLET", "pharm_class": ["Ergolines [CS]", "Ergot Derivative [EPC]"], "product_ndc": "59762-1005", "generic_name": "cabergoline", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cabergoline", "active_ingredients": [{"name": "CABERGOLINE", "strength": ".5 mg/1"}], "application_number": "NDA020664", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20140922", "listing_expiration_date": "20261231"}